Clinical trial
Seven Day Versus Fourteen-day Corticosteroid in Patients With Severe Alcohol -Associated Hepatitis- A Double Blind Randomized Controlled Trail (STASH II)
NCT06919458 is registered in ClinicalTrials.gov with Asian Institute of Gastroenterology, India as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Seven Day Versus Fourteen-day Corticosteroid in Patients With Severe Alcohol -Associated Hepatitis- A Double Blind Randomized Controlled Trail (STASH II)
- Lead sponsor
- Asian Institute of Gastroenterology, India
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 7, 2025
- Completion date
- August 15, 2026
- Enrollment
- 151 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
alcoholic hepatitis